Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tong Ren Tang Technologies Co ( (HK:1666) ) has provided an update.
Tong Ren Tang Technologies Co. Ltd. has announced the current composition of its board of directors, comprising executive, non-executive, independent non-executive and an employee director, with Zhang Yi serving as chairman and Zhang Chun You as general manager. The company also confirmed the membership and chairpersons of its four key board committees—Audit, Nomination, Remuneration, and Strategy and Planning—clarifying governance responsibilities and reinforcing its corporate oversight structure, a move that underscores continued emphasis on compliance, strategic planning and stakeholder accountability.
The most recent analyst rating on (HK:1666) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong (Stock Code: 1666). The company operates in the pharmaceutical and traditional Chinese medicine sector, focusing on the production and sale of TCM products and related healthcare offerings in domestic and international markets.
Average Trading Volume: 1,033,606
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.71B
See more data about 1666 stock on TipRanks’ Stock Analysis page.